LDLT
LDLTregistry.org is a non-profit international research registry operating the largest database of living donor liver transplantation outcomes, with 635 members across 52 countries contributing anonymized donor-recipient case data via an electronic Case Report Form.
- Company typePrivate
- Founded2023
- HeadquartersZurich, Switzerland
- Headcount—
- GTM typeB2B
- OfferingSoftware
What LDLT does
LDLTregistry.org operates the International Living Donor Liver Transplant Registry, the largest international outcomes registry of its kind, collecting prospective data on living donor liver transplantation (LDLT) donor-recipient pairs from transplant centers worldwide. The web-based platform enables centers to form local teams (up to 3 investigators plus 1 auditor) and submit anonymized consecutive cases through an electronic Case Report Form (eCRF), with morbidity and mortality tracked through hospital discharge, 90-day postoperative follow-up, and 12-month outcomes. Supporting tooling includes a downloadable paper CRF for offline extraction, clinical conversion calculators, and a data request workflow for approved spin-off studies. The platform uses SSL/TLS encryption, GDPR-compliant storage, and is integrated into ICO and ISRCTN registries; it is accessible on desktop, tablet, or smartphone without API or third-party integrations.
The organization is a non-profit international research collaborative, incorporated in England and Wales as LDLTregistry.org LTD, with its registered office in London and academic headquarters at Klinik Hirslanden in Zurich. Governance rests with founders Dimitri Raptis, Marina Berenguer, Michael Spiro, and Mohamed Rela, supported by Chief Investigators in India, the United States, and Japan, a Country Leaders network of 47, and Scientific, Management, and Administration Committees. Revenue consists entirely of institutional grants and donations, anchored by five-year funding commitments from the iLDLT Group and the International Liver Transplantation Society (ILTS), a grant from The Transplantation Society (TTS), and Platinum/Gold sponsorship from Rela Hospital Chennai and the Valencian Medical Foundation for the Study of Liver Diseases. Participation is free, and PubMed-citable group authorship for all collaborators who submit valid cases is the principal incentive driving member recruitment. Scientific output includes an Editor's Choice article in the American Journal of Transplantation and a comparative outcomes study in Transplantation, with three further manuscripts in production.
LDLT firmographics
Firmographics- Name
- LDLT
- Legal name
- LDLTregistry.org LTD
- Website
- https://ldltregistry.org
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Short description
- LDLTregistry.org is a non-profit international research registry operating the largest database of living donor liver transplantation outcomes, with 635 members across 52 countries contributing anonymized donor-recipient case data via an electronic Case Report Form.
- Ownership category
- akta.pro rank
LDLT industry classification
Industry- Product category
- Clinical Research Registry
- NAICS
- Blood and Organ Banks (621991), Voluntary Health Organizations (813212)
- SIC
- Services-Medical Laboratories (8071), Services-Membership Organizations (8600)
- akta.pro primary industry
- Transplant Hepatology (HLAKAEAK)
- akta.pro secondary industries
- Hepatology & Liver Disease (HLAKAEAB), Blood, Organ & Tissue Donation Organizations (BPAGACAJ)
Keywords
Where LDLT is headquartered
LocationHeadquarters
- HQ city
- Zurich
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
LDLT business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Funding and Grants: LDLTregistry.org is funded through institutional grants and donations. Major funders include iLDLT Group and ILTS (five-year funding commitment), TTS (grant), and individual donors. Additional funding from Rela Hospital Chennai (Platinum), and Valencian Medical Foundation for the Study of Liver Diseases (Gold). The organization also accepts donations. No commercial revenue model exists as this is a non-profit research registry.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
LDLT product offering
Product offeringCore offering
LDLTregistry.org operates an international, web-based patient registry platform that collects and analyzes outcome data on living donor liver transplantation (LDLT) from transplant centers worldwide. Participating centers register teams of investigators and submit consecutive unselected donor-recipient cases through an electronic Case Report Form, capturing donor and recipient morbidity and mortality data through hospital discharge, 90-day follow-up, and 12-month outcomes, with PubMed-citable group authorship granted to contributing collaborators.
Product overview
LDLTregistry.org is a single, unified international clinical registry platform for Living Donor Liver Transplantation (LDLT). The core offering consists of the LDLTregistry.org web-based registry platform that enables international centers to submit consecutive donor-recipient case data through an electronic Case Report Form (eCRF). Supporting tools include downloadable paper CRFs for offline data collection, conversion calculators for clinical parameters, multi-language patient consent forms, and a data access program for spin-off studies. The platform captures morbidity and mortality data for both donors and recipients through hospital discharge and up to 90 days postoperatively, with additional 12-month follow-up outcomes. The registry has no API or third-party integrations but operates as a standalone, secure web platform with SSL/TLS encryption and GDPR-compliant data handling.
Differentiator
Problem solved
Functional benefit
Products and services
- LDLTregistry.org Platform A web-based international clinical registry platform for collecting and analyzing outcomes of living donor liver transplantation (LDLT). Transplant centers register multi-disciplinary teams, submit consecutive unselected donor-recipient cases through an electronic Case Report Form, and receive PubMed-citable group authorship in resulting peer-reviewed publications. Captures donor and recipient morbidity and mortality through hospital discharge, 90-day follow-up, and 12-month outcome data.
- Spin-off Studies Data Access A formal secondary-analysis access program that grants approved investigators anonymized raw registry data for peer-reviewed spin-off studies in living donor liver transplantation. Submissions are made through the Data Request Form by registered members and reviewed by the Data Management Committee under defined governance procedures.
Quantifiable outcome
- First publication in American Journal of Transplantation with cohort of 1,575 donor-recipient pairs providing insights into global variation in LDLT practices
- +2 more outcomes
Companies that use LDLT
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles2 records
LDLT technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
LDLT partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and supporting.
- Klinik HirslandencoreHost institution for the academic headquarters of LDLTregistry.org in Zurich, Switzerland. Endorsed by Hirslanden as a supporting organization.
- IHPBA (International Hepato-Pancreato-Biliary Association)supportingEndorsed by IHPBA as a supporting organization.
- University College London (UCL)supportingAcademic partner of LDLTregistry.org.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
LDLT competitors and assessment
Company assessmentRegional players
- Korean Organ Transplantation Registry (KOTRY): Korean national transplant outcomes registry covering liver, kidney, heart and other organs. Comparable as a structured transplant outcomes data platform with multi-center participation, but limited to Korea and broader in organ coverage.
- NHS Blood and Transplant (NHSBT) UK Transplant Registry: UK national transplant data registry covering solid organ transplantation including liver. Comparable as a transplant outcomes data source for one of LDLTregistry.org's largest contributing markets (UK), though with mandatory national reporting rather than voluntary submission.
- Australia and New Zealand Liver Transplant Registry (ANZLTR): Regional liver transplant outcomes registry for Australia and New Zealand. Comparable in registry design and clinical focus but geographically limited, with several of LDLTregistry.org's country leaders (e.g., Auckland) participating in both initiatives.
Others
- The Transplantation Society (TTS): Global professional society for transplantation and a grant funder of LDLTregistry.org. Comparable in mission alignment (advancing transplantation science globally) and in constituency (transplant clinicians worldwide), but is an umbrella professional body rather than a clinical registry.
- International Living Donor Liver Transplantation Group (iLDLT Group): Professional group dedicated to advancing living donor liver transplantation and the lead five-year funder of LDLTregistry.org. Closely aligned mission and overlapping membership, but focused on education and clinical practice rather than operating a registry platform.
- International Liver Transplantation Society (ILTS): Professional society and a core funder of LDLTregistry.org with a five-year commitment. Comparable in stakeholder base (transplant clinicians and researchers worldwide) and as a convening body for LDLT science, but operates as a membership society rather than a data registry.
Broad incumbents
- United Network for Organ Sharing (UNOS): US non-profit that manages the Organ Procurement and Transplantation Network (OPTN) and operates transplant data systems. Comparable in its role as a transplant data steward serving US centers, but operating under federal contract and with much broader scope than LDLTregistry.org.
- Scientific Registry of Transplant Recipients (SRTR): US national transplant outcomes registry operated under HRSA contract, covering all organ types including liver. Comparable as a transplant outcomes data platform serving transplant centers, but mandated rather than voluntary, and much broader in scope than LDLTregistry.org's living-donor focus.
Direct peers
- European Liver Transplant Registry (ELTR): The longest-running international liver transplant outcomes registry, run under ELITA and supported by ESOT. Directly comparable to LDLTregistry.org in mission (collecting liver transplant outcome data) and customer base (transplant centers), though historically focused on Europe and predominantly deceased-donor cases.
Emerging players
- Center for International Blood and Marrow Transplant Research (CIBMTR): Collaborative research database for hematopoietic cell transplantation outcomes. Comparable as a multi-center, international outcomes registry that provides research access and group authorship to contributing centers — a similar operating model to LDLTregistry.org but in a different therapeutic area.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
LDLT social profiles
Digital presenceLDLT compliance and trust
Trust signalCompliance5 records
LDLT financial estimates
Financial estimateRevenue estimate
Valuation estimate
LDLT leadership team
Management profileNumber of profiles
Profiles12 records
LDLT funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LDLT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LDLT
What does LDLT do?
LDLTregistry.org operates an international, web-based patient registry platform that collects and analyzes outcome data on living donor liver transplantation (LDLT) from transplant centers worldwide. Participating centers register teams of investigators and submit consecutive unselected donor-recipient cases through an electronic Case Report Form, capturing donor and recipient morbidity and mortality data through hospital discharge, 90-day follow-up, and 12-month outcomes, with PubMed-citable group authorship granted to contributing collaborators.
Is LDLT a public or private company?
LDLT is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was LDLT founded?
LDLT was founded in 2023.
Where is LDLT based?
LDLT is headquartered in Zurich, Switzerland, in the Europe region.
How does LDLT make money?
One revenue line is on record: funding and Grants.
Who are LDLT's main competitors?
Regional players on record are Korean Organ Transplantation Registry (KOTRY), NHS Blood and Transplant (NHSBT) UK Transplant Registry and Australia and New Zealand Liver Transplant Registry (ANZLTR). Others are The Transplantation Society (TTS), International Living Donor Liver Transplantation Group (iLDLT Group) and International Liver Transplantation Society (ILTS). Broad incumbents are United Network for Organ Sharing (UNOS) and Scientific Registry of Transplant Recipients (SRTR). European Liver Transplant Registry (ELTR) is listed as a direct peer. Center for International Blood and Marrow Transplant Research (CIBMTR) is listed as an emerging player.
Does LDLT have an API?
No public API is recorded for LDLT.
What industry is LDLT in?
LDLT's product category is Clinical Research Registry. Its primary akta.pro industry code is HLAKAEAK, Transplant Hepatology, with a secondary code of HLAKAEAB, Hepatology & Liver Disease. Its NAICS code is 621991 and its SIC code is 8071.